In 14 countries where all clinics reported to the IVF register, a total of 248 937 ART cycles were performed in a population of 261.6 million, corresponding to 1095 cycles per million inhabitants. For IVF, the clinical pregnancy rates per aspiration and per transfer were 26.6% and 30.1%, respectively. For ICSI, the corresponding rates were 27.1% and 29.8%. After IUI-H, the clinical pregnancy rate was 12.6% in women below 40. After IVF and ICSI, the distribution of transfer of 1, 2, 3 and 4 or more embryos was 19.2%, 55.3%, 22.1% and 3.3%, respectively. Compared with 2003, fewer embryos were transferred, but huge differences still existed between countries. The distribution of singleton, twin and triplet deliveries after IVF and ICSI combined was 77.2%, 21.7% and 1.0%, respectively. This gives a total multiple delivery rate of 22.7% compared with 23.1% in 2003 and 24.5% in 2002. After IUI-H in women below 40 years of age, 11.9% were twin and 1.3% triplet gestations. CONCLUSIONS: Compared with earlier years, the reported number of ART cycles in Europe increased and the pregnancy rates increased marginally, even though fewer embryos were transferred and the multiple delivery rates were reduced.
Introduction
This report is the eighth annual European Society of Human Reproduction and Embryology (ESHRE) publication on European data on assisted reproduction technology (ART). The seven previous reports, also published in Human Reproduction (ESHRE, 2001a (ESHRE, ,b, 2002 (ESHRE, , 2004 (ESHRE, , 2005 (ESHRE, , 2006 (ESHRE, , 2007 , covered treatment cycles from 1997 to 2003 .
Data have been collected from 29 European countries on ART covering IVF, ICSI, frozen embryo replacement (FERs), egg donation (EDs), in vitro maturation (IVM) and pooled data on preimplantation genetic diagnosis (PGD) and screening (PGS) during 2004. Data on intrauterine inseminations using husband/partner's semen 19 countries) and donor semen (IUI-D; 15 countries) were also included. According to the International Committee for Monitoring ART-World Health Organization (ICMART-WHO) definitions (World Health Organization, 2002; Zegers-Hochschild 2006a,b) IUI-H and IUI-D should not be classified as ART. However, the European IVF Monitoring (EIM) Consortium has decided to continue to include the IUI activity in the annual reports. The reasons for this are that IUI is common, contributes to fertility-related births and predisposes to risks such as multiple pregnancy. They also involve the use of donor gametes. Finally, accreditation of all clinics according to the new European Union Tissue and Cell Directive includes all clinics that perform IUI (Directive, 2004) .
The annual meeting with the EIM Consortium was held at the ESHRE meeting in Lyon in July 2007 with representatives from the participating countries. The present and future reporting systems were discussed. The Czech Republic and Croatia were unable to provide data for 2004, but Albania and Turkey joined the consortium and provided data. The Turkish data available are collected by the organization of private IVF centres and covered 4 out of 78 clinics. However, the Turkish Ministry of Health also has a register, and this may for the coming years contribute to the EIM programme. The consortium stressed that efforts should be made to have better coverage in the Balkan and Eastern European countries. Albania  2  1  51  72  0  0  0  0  123  Austria  25  25  1220  3284  4504  Belgium  18  18  4053  9741  4802  513  650  19 759  Bulgaria  14  7  488  440  53  22  0  0  1003  Denmark  21  21  5575  4023  1853  67  11 518  Finland  18  18  2926  1835  3434  872  96  41  9204  France  100  100  23 926  31 291  14 069  264  196  69 746  Germany  120  120  12 211  26 613  17 989  56 813  Greece  49  16  2793  5425  1115  381  0  96  9810  Hungary  11  6  688  1905  256  28  0  1  2878  Iceland  1  1  107  127  73  9  0  0 13  13  9178  6119  69  15 366  Turkey  78  4  28  3444  67  0  0  36  3575  Ukraine  15  11  1078  427  38  59  30  1632  UK  74  74  17 072  13 303  7349  2150  107  39 981  All  1121  785  114 672  167 192  71 997  10 334  170  2701  367 066 For Austria, Belgium, Germany, Iceland, Lithuania and Portugal, 'treatment cycles' for IVF and ICSI refer to aspirations. FER refers to thawings, but for Latvia, it refers to transfers. ED refers to cycles where eggs were donated or to a cycle where donor eggs resulted in embryo transfer in a recipient. For Belgium, preimplantation genetic diagnosis (PGD) refers to transfers. IVM: in vitro maturation. Germany  56 813 75 212 900  19 412 000  755  3  8458  10 270  643 822  1.6  Iceland  316  293 906  50 000  1075  6  64  81  4065  2.0  Latvia  184  2 306 306  564 000  80  0  27  33  20 457  0.2  Macedonia  522  2 071 210  510 000  252  1  59  78  27 216  0.3  Norway  6078  4 574 560  1 058 000  1329  6  1219  1512  54 392  2.8  Slovenia  2725  2 011 473  490 000  1355  6  522  611  17 902  3.4  Sweden  12 871  8 986 400  1 980 000  1432  7  2545  2711  93 998  2.9  The Netherlands 15 366 16 318 199  3 854 000  942  4  186 191  UK  39 981 60 270 708  14 335 000  663  3  8338  10 301  655 745  1.6  All  248 937 261 620 817  63 368 000  1095  4  2 749 571 Data refer to IVF, ICSI, FER and ED combined. a Numbers of the year 2005.
Assisted reproductive technology in Europe, 2004 To that end an ESHRE -EIM workshop was held in Sofia during September 2007. The consortium noted that the quality of data continues to vary between countries. In some large southern European countries, there was scope for improvement in terms of the proportion of clinics providing data: Spain (84/182, 46%), Greece (16/49, 33%) and Italy (133/218, 61%) . In Italy, a mandatory national data collection programme is now established, and both Spain and Greece will follow soon.
In 2004, data collection systems, coverage, definitions and validation still differed between countries. However, since the ESHRE Consortium meeting in Madrid 2003, it was decided that in the coming years the EIM Consortium members should continue to adapt to the definitions listed by the ICMART as originally published in the WHO report (World Health Organization, 2002) , and now in Human Reproduction (Zegers-Hochschild et al., 2006a) and Fertility and Sterility (Zegers-Hochschild et al., 2006b) .
The Consortium decided to continue to present annual reports and to try to improve the quality of the reports.
Materials and Methods

Data collection
The present report summarizes data from ART treatments, including IVF, ICSI, ED, FER, PGD/PGS, IVM and IUI-H and IUI-D started between the 1st of January 2004 and the 31st of December 2004.
Follow-up data on pregnancies and deliveries are cohort data. For IUI only pregnancies, and not deliveries, were recorded. The number of clinics reporting IUI data may differ from the number of clinics presenting data on the in vitro techniques.
As it is evident from the tables, registers from a number of countries have been unable to provide some of the data.
The reporting principle used for 2004 data is basically similar to the preceding years (ESHRE, 2001a (ESHRE, ,b, 2002 (ESHRE, , 2004 (ESHRE, , 2005 (ESHRE, , 2006 (ESHRE, , 2007 .
As the data presented here are incomplete and generated through different methods using different definitions in different countries, interpretation of the data must be done with some caution. Table I shows the number of all treatment cycles recorded in each country, the number of clinics in the country and the number of clinics reporting to the register. The cycles are subdivided into treatment modalities such as IVF, ICSI, FER, ED, IVM and PDG/PGS. In Austria, Belgium, Germany, Iceland, Lithuania and Portugal, the number of oocyte recoveries was used, as the number of initiated cycles was not available. Totally, 785 clinics from 29 countries reported 367 066 cycles.
Results
Number of treatment cycles
The proportion of IVF (114 672) and ICSI (167 192) cycles was 40.7% IVF versus 59.3% ICSI. The proportion of FER cycles compared with 'fresh' cycles were 71 997/281 864 (25.5%). Table II shows data from those 14 countries where all clinics have reported to the register. The number of cycles is related to the total population in the country as well as to the number of females of reproductive age (15 -49 years). Additionally, the number of infants born after ART is expressed as a percentage of the total number of live-born in the country. Overall, 248 937 cycles were undertaken in a population of 261.6 million, giving a mean of 1095 cycles per million. On average, 4 cycles per 1000 women of reproductive age were done. The proportion of infants born after ART in the 14 countries ranged from 0.2% to 4.2%. Table III shows the size distribution of the 785 reporting clinics. The size of a clinic (or unit) is based on all cycles performed per year.
Size of the clinics
The distribution of clinics according to the number of cycles varies considerably among the countries. Among the larger countries, it could be noted that in Italy 40% of the clinics provided fewer than 100 cycles annually, whereas in Belgium 44% of the clinics performed more than 1000 cycles a year.
To what extent these variations may influence results cannot be estimated from the present report. Table IV shows the age distribution of those women treated with IVF or ICSI in various countries. Table V shows the number of embryos transferred after IVF and ICSI combined. The total number of single embryo transfers (SETs) was 43 219 (19.2%), dual embryo transfers (DETs) 124 797 (55.3%), triple embryo transfers 49 843 (22.1%) and four or more embryo transfers 7511 (3.3%). As indicated in this table, major differences were seen between countries. In 2004, several countries reported an increase of SETs. The highest levels were found in Finland (47%), Belgium (49%) and Sweden (67%). The proportion of triple embryo transfers was 0.1% in Sweden to 50% in Lithuania. Transfer of four or more embryos ranged from zero in several countries to 33.2% in Turkey. Tables VI-IX show the number of pregnancies and deliveries in relation to the number of initiated cycles, aspirations and transfers, for IVF (Table VI) , ICSI (Table VIII) , FER (Table VIII) and ED (Table IX) . In Tables VI, VII , VIII and IX, the delivery rates per embryo transfer have not been summarized due to incomplete or absence of follow-up of pregnancies in many countries.
Age distribution
Number of embryos transferred
Pregnancies and deliveries after treatment
Preimplantation genetic diagnosis/screening PGD/PGS activity was recorded from 12 countries, as indicated in Table I : totally it involved two thousand seven hundred and one cycles, 1691 aspirations, 1849 embryo transfers, 789 pregnancies (42.7% per transfer) and 331 deliveries.
In vitro maturation
IVM was recorded in five countries: Finland (96 cycles), Poland (2 cycles), Russia (34 cycles), Serbia and Montenegro (4 cycles) and Slovenia (34 cycles). The 170 cycles resulted in 17 (10%) pregnancies. Table X shows the deliveries after IVF and ICSI in relation to singleton, twin and triplet deliveries. The distribution of the deliveries was: singleton 34 846 (77.2%), twin 9 790 (21.7%) and triplet 438 (1.0%). Table XI shows deliveries after FER in relation to singleton, twin and triplet deliveries. It is seen that the distribution of the deliveries was: singleton 6625 (84.8%), twin 1142 (14.6%) and triplet 36 (0.5%). Total excludes transfers from The Netherlands and Norway as the number of embryos transferred is not known for these countries.
Singleton, twin, triplet and quadruplet deliveries
Risks and fetal reductions
Andersen et al. In women below 40 years of age, 94 100 treatments resulted in 11 866 pregnancies giving a pregnancy rate per procedure of 12.6%. In women at 40 years or above, the corresponding figures were 4288%, 350% and 8.2%.
Intrauterine inseminations
In women below 40, singleton, twin and triplet pregnancies accounted for 86.6%, 11.9% and 1.3% of the pregnancies, respectively, whereas in women above 40 the corresponding figures were 89.3%, 10.4% and 0.3%. Table XIV gives data on IUI-D divided in female age groups below 40 years (upper panel) and 40 years or more (lower panel). For France, no stratification for age was available, and the overall results are included in the group below 40 years of age.
In women below 40 years of age, 15 882 treatments resulted in 2965 pregnancies giving a pregnancy rate per insemination of 18.7%. In women at 40 years or above, the corresponding figures were 1710%, 143% and 8.4%.
In women below 40, singleton, twin and triplet pregnancies accounted for 88.0%, 11.1% and 0.8% of the pregnancies, respectively, whereas in women above 40, the corresponding figures were 91.4%, 7.1% and 1.4%. Table XV gives an estimation of the cumulative delivery rates per initiated fresh stimulated cycle. This is not the real cumulative delivery rate per couple, but shows the number of deliveries obtained from the FER cycles added to the deliveries from the stimulated cycles during the same year. Additionally, the table shows the rate of multiple deliveries after FER and stimulated cycles combined.
Cumulative delivery rates
Comments
The present report is the eighth consecutive, annual European report on ART data. Together, these reports cover treatment cycles from 1997 to 2004. It can be argued that as long as data are incomplete, generated through different methods of data collection and still using partly different definitions, the data should not be summarized, as it occurs in this report. Therefore, the focus should primarily be on specific country data rather than on summary data. In 2004, the number of countries reporting to ESHRE's EIM Consortium increased to 29 countries covering the whole of Western Europe. In Eastern and South Eastern Europe, no data were available from countries such as Bosnia, Croatia, the Czech Republic, Romania and Slovakia.
Compared with 2003, the number of cycles in Germany showed a dramatic fall from 102 426 to only 56 813. This occurred following a more restrictive re-imbursement policy, introduced in January 2004, providing strong evidence that the re-imbursement policy for ART has a major impact on the accessibility and use of these treatments. Data from the German register (www.deutsches-ivf-register. Within Europe, the largest number of cycles from a single country were reported from France (70 000), Germany (57 000), Spain (41 000) and the UK (40 000). In comparison, the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry reported close to 128 000 cycles from the USA in 2004 (Wright et al., 2007) .
We still do not have a complete European set of data, as the present report only includes around 70% of all centres in the reporting countries. However, we believe that those clinics that do not report are likely to be smaller in size than those that do report. In southern Europe, a number of countries still in 2004 had a low coverage among the clinics (Greece 33%; Spain 46% and Italy 61%). In Italy, reporting became mandatory in 2004, but this was not fully implemented. In Greece, a statutory IVF register is going to be established, and the number of reporting clinics from Spain is growing.
The average number of treatment cycles per million inhabitants was 1095 with a range from 80 in Latvia to 2128 in Denmark (Table II) . Another way to define the availability of ART is that four treatment cycles were done per 1000 women of reproductive age (15 -49 years).
The proportion of ICSI versus standard IVF procedures continues to increase (49% in 2001; 52% in 2002; 55% in 2003 and 59% in 2004) . A similar increase has been observed in the USA where the percentage of ICSI cycles reached 57.5% in 2004 (Jain and Gupta, 2007) . Interestingly, the percentage of diagnosis of infertility attributed to male-factor conditions remained This report is unable to define the number of elective SET (eSET) versus SET, but the rise in the number of transfers of one embryo is undoubtedly due to a rise in eSET. As seen in Table V , there were six countries that reported transfer of a single embryo in more than 25% of all transfers. The highest rates were in Finland (47%), Belgium (49%) and Sweden (67%).
The consistent trend towards transfer of fewer embryos is also reflected in the overall occurrence of multiple deliveries after IVF and ICSI. In 2000, the average multiple delivery rate was 26.9%, declining to 25.5% in 2001, to 24.5% in 2002, to 23.1% in 2003 and to 22.7% in 2004 . During the 8 year period of EIM reporting the most remarkable finding regarding multiples has been the reduction in triplet deliveries from 3.6% in 1997, to 2.3% in 1998, 2.3% in 1999, 1.9% in 2000, 1.5% in 2001, 1.3% in 2002, 1.1% in 2003 and 1.0% in 2004 . Still, however, huge differences in triplet rates exist between countries.
When analysing the range of multiple delivery rates in different countries, the number of fetal reductions should also be considered. A total of 526 procedures were reported, the largest numbers coming from France (106), the UK (92), Greece (84) and Spain (83). For 2004, the German data were not available. Without this intervention, the proportion of triplet deliveries would certainly have been higher, considering that a number of countries did not report on fetal reductions, and the fact that the number reported is higher than the number of recorded triplet deliveries that was 438 after IVF/ ICSI and 36 after FER.
Pregnancy 18.6% in 2003. The figures from Europe remain lower than in the USA where 41.5% (fresh embryos) and 35.1% (FER transfers) of ART transfers resulted in a pregnancy (Wright et al., 2007) . However, the multiple birth rates in the USA were also considerably higher at 34% after fresh transfers and 28% after FER transfers. With a noticeable decline in the number of embryos transferred, the cumulative delivery rate per started cycle may be a most relevant end-point for ART. Table XV gives a calculation of cumulative delivery rates, but it should be stressed that this does not represent the true cumulative delivery rate per cycle and per couple, but only gives an estimation based on fresh and FER cycles done during the same year. In a steady-state situation, this calculation will give a rather good estimate of the true cumulative delivery rate. An example of expressing outcomes in this manner is data from Finland where the delivery rate per fresh cycle was 18.6%, the cumulative delivery rate after frozen replacement of embryos reached 29.5%, with an overall multiple delivery rate of 12.3%. For Sweden, the delivery rate increased from 21.1% to 26.3% per started cycle, with only 6.5% multiple deliveries. In the UK, the corresponding rates for live births were 22.2% and 25.7%, and the multiple delivery rates were 23.1%. In conclusion, the FER cycles add a considerable number of deliveries in some countries. PGD/PGS activity was recorded from 12 countries, as indicated in Table I : totally it involved 2051 cycles, 1691 aspirations, 1849 embryo transfers, 789 pregnancies (42.7% per transfer) and 331 deliveries.
Altogether, 2051 cycles with PGD/PGS were reported, compared with 1956 in 2003. ESHRE has a specially focused and more comprehensive reporting on PGD by the sixth ESHRE PGD Consortium report, which included a total of 2984 cycles in 2003. The two reporting systems are different, as the PGD Consortium bases their reports on detailed data from individual clinics. A comparison indicates that the number of PGD cycles reported to the National registers, only include around two thirds of the total activity (Sermon et al., 2007) .
Regarding direct risks of ART, OHSS was recorded in 1.2% of cycles, and during 2004 a total of four maternal deaths were recorded. We do not have data regarding the causes of these tragic events.
For the third consecutive year, the present report includes European data on treatments with IUI-H (98 388 cycles) and IUI-D (17 592 cycles). The coverage of IUI activities by the national registers is much less comprehensive than for the in vitro techniques. In women below 40 years of age, the pregnancy rate was 12.6% for IUI-H and 18.7% for IUI-D. In women at 40 years or above, the corresponding figures were 8.2% and 8.4%. The recording of deliveries is incomplete. For Greece in 2 pregnancies, no further data were available. For Russia in 56 pregnancies, no further data were available.
Note that the recording of deliveries is incomplete due to loss of follow-up in several countries.
After IUI-H in women below 40 years of age, twin pregnancies occurred in 11.9% and triplet pregnancies in 1.3%. The data suggest that the twinning rates are only half of what is found with the in vitro techniques, but triplet rates are marginally higher.
In summary, the present eighth ESHRE report on ART for Europe in 2004 shows a continuing expansion of numbers of participating clinics, countries and treatment cycles reported. Pregnancy rates after IVF, ICSI and FER were all marginally increased compared with 2003, but fewer embryos were transferred and multiple delivery rates continued to decline accounting for 21.7% of all deliveries after IVF and ICSI. eSET had a considerable impact in Belgium, Finland and Sweden and several other countries transferred a single embryo in more than 25% of cycles. This transfer policy is now documented, on a national basis, to reduce multiple delivery rates after transfer of fresh embryos. The multiple delivery rates after IVF and ICSI were 5.6% in Sweden, 10.4% in Belgium and 13.3% in Finland. Twin gestations seem to be much less frequent after IUI-H and IUI-D compared France: for all 'lost to follow up' cases there was delivery, but no details could be reported. For France all treatments are classified as being in women ,40 years, because of lack of age stratification. Distribution of singleton versus multiple gestations is based on deliveries.
Andersen et al. For France all treatments are classified as being in women ,40 years, because of lack of age stratification. Distribution of singleton versus multiple gestations is based on deliveries. 
